Technological advancement. HEOR Teams are embracing digital technology and are investing in areas like AI, digital health, and real-time data analytics to provide insights for payer engagements. For ...
The HEOR capability within the pharmaceutical industry is at a tipping point.On one hand are two well-attended recent conferences (ISPOR-US and EU, 2024) with a total of over 10,500 attendees joining ...
As local payers come under more pressure to constrain costs, the value of Health Economics and Outcomes Research (HEOR) is increasing. The involvement of market access teams at every stage of ...
Open Health has joined forces with health economics and outcomes research (HEOR) company Pharmerit International in a move that strengthens its existing market access capabilities. The integration ...
With over 25 years of experience providing high-quality strategic Market Access and HEOR solutions, at companies including Genesis Research Group, Takeda and Merck Serono, Stephen is a widely ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback